PLG acquires Commercial Eyes, expanding its footprint in the APAC Region

ProductLife Group expands its expertise in APAC through the acquisition of Commercial Eyes Pty Ltd, Australia’s leading pharmaceutical and medical device commercialization company, specializing in regulatory affairs, pharmacovigilance, medical information, quality assurance, market access, market research, and patient programs.

In 2023, our team worked diligently to continue incorporating Corporate Social Responsibility (CSR) and ESG into our business model and practices

Xavier Duburcq, the CEO of PLG, discusses three key highlights and milestones in Corporate Social Responsibility (CSR) from the previous year that lay the foundation for our initiatives in 2024. Our focus included strengthening CSR governance and Environmental, Social, and Governance (ESG) readiness, highlighted by the appointment of Naomi Jade Kellogg as the global CSR Manager. Additionally, we are proud to maintain our Silver Medal status from EcoVadis. Furthermore, we have pledged to establish short-term targets as part of the Science Based Targets Initiative (SBTI). We encourage all stakeholders to play their part by setting decarbonization targets, conducting due diligence on their value chains, and investing in their workforce. Here’s to a successful 2024 and the future ahead!

New regulatory thinking is needed for AI-based personalized drug and cell therapies in precision oncology

Gabrièle Breda, our Research & Innovation Director, and Bouchra D., our Innovation Product Development Officer, have contributed to the comparative analysis of EU and FDA regulations for Drug and digital Device/AI pairings and provided illustrative examples and references in their latest article, “New regulatory thinking is needed for AI-based personalized drug and cell therapies in precision oncology” published today in “npj Precision Oncology”.

Navigating success: the vital role of Good Distribution Practices (GDP) in the logistics landscape

The distribution of goods is a significant concern to businesses throughout all industries. When distributing pharmaceutical and medicinal products, the stakes are raised even further. For many of these products, some specific requirements and regulations must be followed to ensure the safety and quality of the products for human benefit. This is where the principles of Good Distribution Practices shine as the standard’s beacon to ensure that pharmaceutical and medical products arrive to needful patients.

Usability testing of the medicine bottles and readability testing of the documents accompanying medical devices

Innovation continues to drive the medical industry forward. When we think of “innovation,” we think of computers with Machine Learning and Artificial Intelligence driving a revolutionary and limitless future. Innovation is built upon the foundation of improvement, and at PLG, we believe a more subtle side to progress exists. There haven’t been vast changes in the Readability Testing space recently, but the status quo is changing with more complex medications coming to the forefront. PLG has been recognized as a leader in the industry regarding standard Readability testing, and we are now pushing forward to cover Usability Testing of different types of packaging/relevant documents, such as the ones accompanying a medical device.


How to automate regulatory processes thanks to RIMS solutions

We are all aware of a RIM system as a tool to help manage your regulatory data. The modularity of RIM systems ensures they can be tailored to your specific needs. As a global consultancy, the main question is, “How can this tool help the company and my team be more efficient?”. The main benefits lie in the automation of regular processes. Look at the following article to understand more about the automation processes available through a RIMS tool. It will enlighten you on how to save time, remain compliant, increase agility, and manage your data centrally.

Register to our news and events

Go to our Events to register
Go to our News to get insights

February 2024 Monthly Newsletter